Skip to content
Triangle logo TriangleGet started
← Mycosis Fungoides and Other Cutaneous T-Cell Lymphomas

HEALTH PROFESSIONAL · SOURCE READING

Allogeneic stem cell transplant

Source: Mycosis Fungoides and Other Cutaneous T-Cell Lymphomas Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: February 19, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Recurrent Mycosis Fungoides and Sézary Syndrome / Treatment Options for Recurrent Mycosis Fungoides and Sézary Syndrome

Allogeneic stem cell transplant (SCT).[41-43,43-45]

Source links and citations

Allogeneic stem cell transplant (SCT).[41-43,43-45]

Among highly selected patients, the 5-year overall survival (OS) rate ranges from 30% to 50%, with a relapse-free survival rate of 15% to 25%.[41-45]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice